These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6173990)

  • 1. Formation of glutathionedopa in albino rats after DOPA injection.
    Fehling C; Hansson C; Poulsen J; Rorsman H; Rosengren E
    Acta Derm Venereol; 1981; 61(4):339-42. PubMed ID: 6173990
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracellular distribution of dopa and 5-S-cysteinyldopa in pigment cells with minimal pigment formation.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(4):355-6. PubMed ID: 92151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 5-S-cysteinyldopa concentrations in oculocutaneous albinism.
    Nimmo JE; Hunter JA; Percy-Robb IW; Jay B; Phillips CI; Taylor WO
    Acta Derm Venereol; 1985; 65(2):169-71. PubMed ID: 2408424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of dopa in the skin of black and albino mice.
    Carstam R; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1986; 66(5):369-74. PubMed ID: 2431571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of dopa in human albinism.
    Carstam R; Hansson C; Krook G; Rorsman H; Rosengren E; Wirestrand LE
    Acta Derm Venereol; 1985; 65(5):435-7. PubMed ID: 2416170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of cysteinyldopa from glutathionedopa in melanoma.
    Agrup G; Falck B; Kennedy BM; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):1-3. PubMed ID: 46665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methaemoglobin-catalysed formation of dopa and 6-OH-dopa from tyrosine.
    Agrup G; Hansson C; Rorsman H; Rosengren E; Tegner E
    Acta Derm Venereol; 1983; 63(2):152-5. PubMed ID: 6189332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1978; 58(3):270-2. PubMed ID: 78645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pronounced formation of 5-OH-dopa at enzymatic oxidation of DOPA in the presence of ascorbic acid.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1981; 61(2):147-8. PubMed ID: 6165191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic nevi.
    Halldin MM; Cook WS; Kawashima T; Crutcher WA; Fukuyama K
    Cancer Res; 1987 Jan; 47(2):636-8. PubMed ID: 3098416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 5-S-L-cysteinyl-glycine-L-dopa, a natural substrate for serum and melanocyte dipeptidase.
    Kågedal B; Gawelin AL; Pettersson A
    Anal Biochem; 1987 Aug; 165(1):167-74. PubMed ID: 3120620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High-performance liquid chromatographic determination of urinary 5-S, 2-S-, 6-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa (author's transl)].
    Morishima T; Saito M; Fujita M; Fukada E; Hanawa S
    Nihon Hifuka Gakkai Zasshi; 1982 Jan; 92(1):53-6. PubMed ID: 6804671
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopaquinone addition products in cultured human melanoma cells.
    Carstam R; Hansson C; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1987; 67(2):100-5. PubMed ID: 2438872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
    Agrup G; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathionedopa in malignant melanoma.
    Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1977; 57(3):221-2. PubMed ID: 71825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal mitosis is regulated by dopa, a melanin precursor that may influence the time at which cells exit the cell cycle: analysis of patterns of cell production in pigmented and albino retinae.
    Ilia M; Jeffery G
    J Comp Neurol; 1999 Mar; 405(3):394-405. PubMed ID: 10076934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on PUVA treatment of psoriasis and on 5-S-cysteinyldopa after exposure to UV light.
    Tegner E
    Acta Derm Venereol Suppl (Stockh); 1983; 107():1-68. PubMed ID: 6410637
    [No Abstract]   [Full Text] [Related]  

  • 19. Blindness resulting from vitamin A deficiency in albino and pigmented guinea pigs and rats.
    Lewin DR; Thompson JN; Pitt GA; Howell JM
    Int Z Vitaminforsch; 1970; 40(3):270-83. PubMed ID: 5450991
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-OH-dopa, product of and substrate for tyrosinase.
    Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1982; 62(5):371-76. PubMed ID: 6183884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.